Pier Capital, LLC

Position in ROIV — Roivant Sciences Ltd.

CIK 1310051 STAMFORD, CT

Position in ROIV

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$6,290,476

-$2,195,547 QoQ

Shares Held

227,093

-41.9% QoQ

Ownership

0.032%

of shares outstanding

% of Portfolio

1.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 65% Shared 0% None 35%

Healthcare · as of Mar 31, 2026

Pier Capital, LLC holds $20,446,999 across 6 Biotechnology names. ROIV ranks #1 (30.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd. This page	227,093	$6,290,476
2	CYTK	Cytokinetics Inc	69,583	$4,586,215
3	COGT	Cogent Biosciences, Inc.	101,304	$3,899,190
4	GPCR	Structure Therapeutics Inc.	47,551	$2,291,958
5	OLMA	Olema Pharmaceuticals, Inc.	136,108	$2,029,370
6	CAPR	Capricor Therapeutics, Inc.	44,401	$1,349,790

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,290,476	227,093	-41.9%	Shares	Sole	2026-05-14
2025-12-31	$8,486,023	391,061	-0.9%	Shares	Sole	2026-02-03
2025-09-30	$5,971,568	394,684	-0.4%	Shares	Sole	2025-11-13
2025-06-30	$4,466,346	396,304	-7.4%	Shares	Sole	2025-08-05
2025-03-31	$4,319,962	428,143	+1.3%	Shares	Sole	2025-05-13
2024-12-31	$5,000,895	422,730	-1.7%	Shares	Sole	2025-02-11
2024-09-30	$4,961,138	429,908	+1.1%	Shares	Sole	2024-11-15
2024-06-30	$4,493,169	425,087	+29.5%	Shares	Sole	2024-08-07
2024-03-31	$3,459,038	328,182	-0.9%	Shares	Sole	2024-05-03
2023-12-31	$3,720,128	331,267	-1.1%	Shares	Sole	2024-02-15
2023-09-30	$3,912,835	335,003	-45.5%	Shares	Sole	2023-11-14
2023-06-30	$6,198,544	614,935	-0.2%	Shares	Sole	2023-08-14
2023-03-31	$4,545,629	615,939	—	Shares	Sole	2023-05-10
No filing history on record for this holder in this stock.